We are delighted to announce that, from April 2022, Inflammatory Intestinal Disease (IID) will become the official journal of the Japanese Society of Inflammatory Bowel Diseases (JSIBD). Founded in 2009 as a study group specializing in IBD, JSIB has grown to become a leading medical association with the mission to advance care and improve the quality of life of IBD patients by promoting research and education in all aspects of inflammatory bowel diseases. The Society consists of over 900 Japanese researchers and health care professionals interested in IBD and organizes an annual scientific meeting to foster collaboration, support wider education, and advance IBD research in Japan.
IID was launched in 2016 under the editorial leadership of Gerhard Rogler and Toshifumi Hibi. The journal aimed to promote the collaboration between clinical and basic science in IBD and related intestinal diseases and contribute to the knowledge exchange between researchers from Western and Eastern countries. This aim does reflect in the composition of the international editorial board with experts from South Korea, China, India, Taiwan, Singapore, Indonesia, Europe, North and South America, South Africa, Brazil, and New Zealand. Three members from JSIBD have now joined the editorial board as Associate Editors.
In 2021, IID has been indexed in Scopus, reflecting the high quality of the journal and articles published. We would like to thank all our authors for submitting their work to the journal and all our editors who kindly accepted to review papers. Their efforts have been indispensable to launch the journal and grow it over the past 6 years.
We are confident that our new collaboration with JSIBD will support the journal's mission to become a key resource for the international IBD community and ultimately contribute to improve the care and quality of life of patients with IBD. We sincerely welcome researchers from all over the world to publish their studies in IID and foster collaboration between Eastern and Western research communities.
Toshifumi Hibi, Gerhard Rogler
Editors-in-Chief, Inflammatory Intestinal Diseases
Conflict of Interest Statement
The authors declare no conflicts of interest.
Funding Sources
No specific funding was associated with the preparation of this editorial.
Author Contributions
Both the authors contributed equally to the preparation of this editorial.
